image210

When introduced via intraperitoneal injection at 300 ng, we achieved the holy grail of multiple sclerosis, No Evidence of Disease Activity (NEDA)! We were also successful at preventing onset of experimental autoimmune encephalomyelitis (EAE), or mouse MS.